deuterium has been researched along with Dermatitis, Atopic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
James, JM; Kagey-Sobotka, A; Sampson, HA | 1 |
Ahrens, C; Grether-Beck, S; Grewe, M; Kapp, A; Karmann, K; Klotz, LO; Krutmann, J; Morita, A; Ruzicka, T; Sies, H; Stege, H; Werfel, T | 1 |
Ayala, F; Giugliano, R; Lembo, G; Marone, G | 1 |
Bonini, S; Celestino, D; Giugliano, R; Marone, G; Poto, S | 1 |
4 other study(ies) available for deuterium and Dermatitis, Atopic
Article | Year |
---|---|
Patients with severe atopic dermatitis have activated circulating basophils.
Topics: Adolescent; Adult; Basophils; Child; Child, Preschool; Dermatitis, Atopic; Deuterium; Deuterium Oxide; Female; Histamine Release; Humans; Infant; Male; SRS-A; Water | 1993 |
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy.
Topics: Antibodies, Blocking; Apoptosis; Dermatitis, Atopic; Deuterium; Fas Ligand Protein; fas Receptor; Humans; Ligands; Membrane Glycoproteins; Naphthols; Oxygen; Singlet Oxygen; Sodium Azide; T-Lymphocytes, Helper-Inducer; Ultraviolet Therapy | 1997 |
Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis.
Topics: Adolescent; Antibodies, Anti-Idiotypic; Basophils; Calcimycin; Child; Child, Preschool; Dermatitis, Atopic; Deuterium; Deuterium Oxide; Histamine Release; Humans; Immunoglobulin E; Infant; N-Formylmethionine Leucyl-Phenylalanine; Water | 1986 |
Control mechanisms of human basophil releasability.
Topics: Age Factors; Animals; Antibodies, Anti-Idiotypic; Asthma; Basophils; Calcimycin; Dermatitis, Atopic; Deuterium; Deuterium Oxide; Histamine Release; Humans; Hypersensitivity; Immunoglobulin E; N-Formylmethionine Leucyl-Phenylalanine; Phenotype; Water | 1986 |